Press Releases July 16, 2026 04:05 PM

GSI Technology to Announce Fiscal First Quarter 2027 Results on July 30, 2026

GSI Technology schedules fiscal Q1 2027 earnings release and conference call for July 30, 2026

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
GSIT

GSI Technology, a US-based innovator in AI and high-performance compute processing with its Associative Processing Unit (APU) technology, announced it will release its fiscal first quarter 2027 financial results on July 30, 2026, followed by a management conference call to discuss results and outlook.

GSI Technology to Announce Fiscal First Quarter 2027 Results on July 30, 2026
GSIT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • GSI Technology will report Q1 fiscal 2027 results after the market closes on July 30, 2026.
  • The company specializes in AI and compute-in-memory technology through its APU products Gemini-I and Gemini-II, catering to edge computing and high-performance computing markets.
  • A conference call and webcast will be hosted to provide investor insights into the company's performance and outlook for Q2 fiscal 2027.

SUNNYVALE, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute processing, providing true compute-in-memory technology, will announce financial results for its fiscal first quarter 2027 ended June 30, 2026 after the market close on Thursday, July 30, 2026. Management will also conduct a conference call to review the Company's first quarter financial results and its current outlook for the second quarter of fiscal 2027 at 1:30 p.m. Pacific time (4:30 p.m. Eastern Time) on the same day.

To participate in the call, please dial 1-877-407-3982 in the U.S. or 1-201-493-6780 internationally approximately 10 minutes before the start time above, and provide the Conference ID 13761498 The call will also be streamed live via the internet at https://ir.gsitechnology.com. 

A replay will be available from July 30, 2026, at 7:30 p.m. Eastern Time through August 6, 2026, at 11:59 p.m. Eastern Time. To access the replay, dial toll-free in the U.S. at 1-844-512-2921 or internationally at 1-412-317-6671, and enter PIN 13761498. A webcast of the call will be archived on the Company’s investor relations website under the Events and Presentations tab.

ABOUT GSI TECHNOLOGY
GSI Technology is at the forefront of the AI revolution with our groundbreaking APU technology, designed for unparalleled efficiency in billion-item database searches and high-performance computing. GSI’s innovations, Gemini-I® and Gemini-II®, offer scalable, low-power, high-capacity computing solutions that redefine edge computing capabilities. GSI Technology is headquartered in Sunnyvale, California, and has sales offices in the Americas, Europe, and Asia. For more information, please visit www.gsitechnology.com.

Contacts:

Investor Relations:
Hayden IR
Kim Rogers
385-831-7337
[email protected]

Media Relations:
Finn Partners for GSI Technology
Ricca Silverio
415-348-2724
[email protected]

Company:
GSI Technology, Inc.
Douglas M. Schirle
Chief Financial Officer
408-331-9802


Risks

  • The press release contains no specific financial guidance or performance indicators, leading to uncertainty about upcoming results impacting investor sentiment.
  • Market conditions affecting demand for AI and high-performance computing products could influence GSI's performance and stock price.
  • Technological advancements and competitive pressures in the semiconductor and AI hardware sectors pose ongoing business risks for GSI Technology.

More from Press Releases

Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM Aug 30, 2026 Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 Aug 29, 2026 Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Aug 29, 2026 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity Aug 28, 2026 Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update Aug 28, 2026